Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Nausea and Vomiting (CINV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06950632
What this trial is testing

This Study Will Investigate the Effectiveness of Peppermint Oil Inhalation in Reducing the Intensity and Frequency of Acute Nausea and Vomiting Among Cancer Patients Undergoing Chemotherapy. Chemotherapy-induced Nausea and Vomiting (CINV) Are Among the Most Distressing Side Effects Experienced by pa

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
University of Health Sciences Lahore 106
Not applicableLooking for participantsNCT06756022
What this trial is testing

Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
Anhui Provincial Children's Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00787566
What this trial is testing

Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Shin Nippon Biomedical Laboratories, Ltd. 68
Testing effectiveness (Phase 2)Study completedNCT03097588
What this trial is testing

Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant

Who this might be right for
Malignant Neoplasm
OHSU Knight Cancer Institute 43
Post-approval studies (Phase 4)UnknownNCT02576327
What this trial is testing

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Vomiting
Jun Zhu 130
Testing effectiveness (Phase 2)Study completedNCT01697579
What this trial is testing

Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Merck Sharp & Dohme LLC 240
Testing effectiveness (Phase 2)Ended earlyNCT03008213
What this trial is testing

Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory CINV

Who this might be right for
Chemotherapy Induced Nausea Vomiting
Joseph Ma 4
Testing effectiveness (Phase 2)Study completedNCT03948477
What this trial is testing

Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy

Who this might be right for
OncologyBreast CancerChemotherapy-induced Nausea and Vomiting
University of Auckland, New Zealand 160
Post-approval studies (Phase 4)Study completedNCT00090207
What this trial is testing

Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)

Who this might be right for
NauseaVomiting
Merck Sharp & Dohme LLC 477
Testing effectiveness (Phase 2)Study completedNCT01054456
What this trial is testing

Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)

Who this might be right for
Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC
Eisai Inc. 36
Post-approval studies (Phase 4)Study completedNCT01659775
What this trial is testing

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)

Who this might be right for
Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
LG Life Sciences 389
Testing effectiveness (Phase 2)Study completedNCT04592198
What this trial is testing

Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting

Who this might be right for
Nausea With Vomiting Chemotherapy-Induced
Xiamen LP Pharmaceutical Co., Ltd 22
Not applicableUnknownNCT03601871
What this trial is testing

The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Yunpeng Liu 880
Testing effectiveness (Phase 2)UnknownNCT06065722
What this trial is testing

Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
Simon Williamson Clinic 100
Testing effectiveness (Phase 2)UnknownNCT04472143
What this trial is testing

Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents

Who this might be right for
Chemotherapy-induced Nausea and Vomiting (CINV)
Fudan University 60
Large-scale testing (Phase 3)Study completedNCT02106494
What this trial is testing

A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Heron Therapeutics 942
Large-scale testing (Phase 3)Study completedNCT03403712
What this trial is testing

Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Helsinn Healthcare SA 404
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07246070
What this trial is testing

Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
AIPING ZHOU 127
Post-approval studies (Phase 4)Not Yet RecruitingNCT05841849
What this trial is testing

Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer

Who this might be right for
Breast CancerChemotherapy-induced Nausea and Vomiting
Second Affiliated Hospital, Zhejiang University, School of Medicine 1,028
Large-scale testing (Phase 3)Study completedNCT00952341
What this trial is testing

Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 421
Next Page